Global Technology – October 2019

In experiments with mice, UCLA researchers have shown they can harness the power of invariant natural killer T cells (or INKT) to attack tumor cells and treat cancer.  The new method, described recently in the journal Cell Stem Cell, suppressed the growth of multiple types of human tumors that had been transplanted into the animals.

What’s really exciting is that doctors can give this treatment just once and it increases the number of invariant natural killer T cells to levels that can fight cancer for .....

This content is for BUSINESS BRIEFINGS members only.